Cassopeia Pharmaceuticals Pvt

Company snapshot

Welcome to Cassopeia Pharma, a leading pharmaceutical company dedicated to improving global health and transforming lives through innovative medical solutions. With a relentless focus on research, development, and manufacturing of high-quality pharmaceutical products, we are committed to meeting the diverse needs of patients and healthcare professionals worldwide. At Cassopeia Pharma, our core mis

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 12 US patent(s) indexed to this assignee profile.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Cassopeia Pharmaceuticals Pvt. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Cassopeia Pharmaceuticals Pvt.

1. Jun 8, 2026 Clinical update

   CB-03-01/39 — Phase 1

2. Apr 30, 2026 Patent grant

   FORMULATIONS DE CLASCOTÉRONE ET LEURS MÉTHODES D'UTILISATION

3. Mar 19, 2026 Patent grant

   POLYTHÉRAPIE À BASE DE CLASCOTÉRONE ET DE MINOXIDIL POUR LE TRAITEMENT DE LA PERTE DES CHEVEUX

4. Aug 21, 2025 Patent grant

   POLYTHÉRAPIE À BASE DE PYRILUTAMIDE

5. Jun 19, 2025 Patent grant

   COMBINAISONS DE CORTEXOLONE-17ΑLPHA-PROPIONATE POUR LE TRAITEMENT DE L'ACNÉ

View all clinical trial activity →

• What is Cassopeia Pharmaceuticals Pvt?

  Cassiopea S.p.A is a pharma organization headquartered in LAINATE, IT. Primary therapeutic focus areas include Test of vasocontriction properties for classification of topical steroid potency. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) t

• Is Cassopeia Pharmaceuticals Pvt publicly traded?

  Cassopeia Pharmaceuticals Pvt appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Cassopeia Pharmaceuticals Pvt develop or market?

  We link 6 drug profile(s) where Cassopeia Pharmaceuticals Pvt is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/cassiopea-s-p-a#company-drugs.

• What are the latest developments for Cassopeia Pharmaceuticals Pvt?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Cassopeia Pharmaceuticals Pvt focus on?

  Cassopeia Pharmaceuticals Pvt focuses on Test of vasocontriction properties for classification of topical steroid potency based on our analysis of their pipeline programs and drug development activities.